BlossomHill Therapeutics announced FDA alignment on a 50 mg twice daily dose for BH-30643, an investigational drug targeting EGFR C797S-positive non-small cell lung cancer (NSCLC). The company plans to start the pivotal Phase 2 SOLARA-2 trial in early 2027, aiming to support accelerated approval for patients with limited treatment options. BH-30643 has shown promising anti-tumor activity and received Fast Track designation, with the trial including both chemotherapy-naive and pretreated patients. This development marks a significant step toward addressing resistance in EGFR-mutant NSCLC.
BlossomHill Therapeutics' recent FDA meeting and trial plans provide context for health sector activity. For readers following health stocks, 108 of 150 US health-sector stocks rose while 26 fell on Pluang. Notable movers included CTXR at USD 0.54 (-2.98%), HIMS at USD 25.29 (-2.73%), and MRVI at USD 7.35 (-2.26%). Data is as of Nov 09, 2026 18:41 WIB.
Neo Security, Inc. has launched Neoverse, a free AI software intelligence engine that researches and classifies over 4 million AI apps, extensions, and servers to assess their capabilities and security risks. Integrated into Neo's platform, Neoverse ...
AnorTech Inc. completed a $7.55 million share exchange with Nasdaq-listed Greenland Mines, increasing Greenland Mines' ownership in AnorTech to 19.9%. Greenland Mines acquired over 25 million AnorTech shares in exchange for Greenland Mines shares val...
Microsoft will retire the backend services for its UWP Map Control and Windows Maps APIs on November 30, 2026, ending map functionality in many Windows desktop and tablet applications. OnTerra Systems, a Microsoft partner, has developed an off-the-sh...
Marengo Therapeutics presented interim Phase 2 results from the STARt-002 trial combining invikafusp alfa, a selective T-cell agonist, with sacituzumab govitecan in metastatic triple-negative and HR-positive/HER2-negative breast cancer. The trial sho...
Holzer & Holzer, LLC announced deadlines for investors to seek lead plaintiff status in shareholder class action lawsuits against The Ensign Group, Netcapital Inc., and Webull Corporation. These lawsuits allege misleading statements and failure to di...
